XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.3
Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Stock by Class
Preferred stock authorized, issued and outstanding was as follows:
September 30, 2025December 31, 2024
SeriesShares
Authorized
Shares Issued and
Outstanding
Shares
Authorized
Shares Issued and
Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A27,600,000 24,000,000 27,600,000 24,000,000 
5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D500,000 500,000 500,000 500,000 
5.625% Non-Cumulative Preferred Stock, Series E32,200 32,200 32,200 32,200 
4.75% Non-Cumulative Preferred Stock, Series F40,000 40,000 40,000 40,000 
3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G
1,000,000 — 1,000,000 1,000,000 
Series A Junior Participating Preferred Stock10,000,000 — 10,000,000 — 
Not designated160,827,800 — 160,827,800 — 
Total200,000,000 24,572,200 200,000,000 25,572,200 
Dividends Declared
The per share and aggregate dividends declared for MetLife, Inc.’s preferred stock were as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
2025202420252024
SeriesPer ShareAggregatePer ShareAggregatePer ShareAggregatePer ShareAggregate
(In millions, except per share data)
(In millions, except per share data)
A$0.353 $$0.417 $10 $1.059 $25 $1.267 $30 
D$29.375 14 $29.375 14 $58.750 29 $58.750 29 
E$351.563 12 $351.563 11 $1,054.689 34 $1,054.689 34 
F$296.875 12 $296.875 12 $890.625 36 $890.625 36 
G$19.250 20 $19.250 20 $38.500 39 $38.500 39 
Total$66 $67 $163 $168 
Class of Treasury Stock
MetLife, Inc. announced that its Board of Directors authorized common stock repurchases as follows:
Announcement DateAuthorization Amount
Authorization Remaining at
September 30, 2025 (1)
(In millions)
April 30, 2025$3,000 $2,502 
May 1, 2024$3,000 $— 
May 25, 2023$1,000 $— 
May 3, 2023$3,000 $— 
__________________
(1)The Inflation Reduction Act, signed into law on August 16, 2022, imposes a one percent excise tax, net of any allowable offsets, on certain corporate stock buybacks made after December 31, 2022. The authorization remaining at September 30, 2025 does not reflect the applicable excise tax payable.
Components of Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc. was as follows:
Three Months
Ended
September 30, 2025
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Deferred
Gains (Losses)
on Derivatives
FPBs Discount
Rate
Remeasurement
Gains (Losses)
MRBs
Instrument-
Specific Credit
Risk
Remeasurement
Gains (Losses)
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period$(16,484)$(1,466)$5,876 $(64)$(6,314)$(1,407)$(19,859)
OCI before reclassifications2,352 149 (65)(24)154 (1)2,565 
Deferred income tax benefit (expense)(585)(42)217 (55)— (460)
AOCI before reclassifications, net of income tax(14,717)(1,359)6,028 (83)(6,215)(1,408)(17,754)
Amounts reclassified from AOCI62 154 — — — 22 238 
Deferred income tax benefit (expense)(12)(34)— — — (4)(50)
Amounts reclassified from AOCI, net of income tax50 120 — — — 18 188 
Balance, end of period$(14,667)$(1,239)$6,028 $(83)$(6,215)$(1,390)$(17,566)
Three Months
Ended
September 30, 2024
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Deferred
Gains (Losses)
on Derivatives
FPBs Discount
Rate
Remeasurement
Gains (Losses)
MRBs
Instrument-
Specific Credit
Risk
Remeasurement
Gains (Losses)
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period$(19,187)$99 $6,606 $(73)$(6,785)$(1,396)$(20,736)
OCI before reclassifications9,942 125 (5,891)99 349 4,627 
Deferred income tax benefit (expense)(2,082)(101)1,289 (22)90 (1)(827)
AOCI before reclassifications, net of income tax(11,327)123 2,004 (6,346)(1,394)(16,936)
Amounts reclassified from AOCI121 (607)— — — 32 (454)
Deferred income tax benefit (expense)(33)192 — — — (9)150 
Amounts reclassified from AOCI, net of income tax88 (415)— — — 23 (304)
Balance, end of period$(11,239)$(292)$2,004 $$(6,346)$(1,371)$(17,240)
Nine Months
Ended
September 30, 2025
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Deferred
Gains (Losses)
on Derivatives
FPBs Discount
Rate
Remeasurement
Gains (Losses)
MRBs
Instrument-
Specific Credit
Risk
Remeasurement
Gains (Losses)
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance at December 31, 2024
$(19,402)$370 $6,529 $(71)$(7,170)$(1,442)$(21,186)
Cumulative effects of change in accounting principles for equity method investees at January 1, 2025
70 — (1,144)— — — (1,074)
OCI before reclassifications5,464 (662)867 (15)934 (8)6,580 
Deferred income tax benefit (expense)(1,115)109 (224)21 (1,204)
AOCI before reclassifications, net of income tax(14,983)(183)6,028 (83)(6,215)(1,448)(16,884)
Amounts reclassified from AOCI403 (1,327)— — — 75 (849)
Deferred income tax benefit (expense)(87)271 — — — (17)167 
Amounts reclassified from AOCI, net of income tax 316 (1,056)— — — 58 (682)
Balance, end of period$(14,667)$(1,239)$6,028 $(83)$(6,215)$(1,390)$(17,566)
Nine Months
Ended
September 30, 2024
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Deferred
Gains (Losses)
on Derivatives
FPBs Discount
Rate
Remeasurement
Gains (Losses)
MRBs
Instrument-
Specific Credit
Risk
Remeasurement
Gains (Losses)
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period$(14,506)$183 $2,658 $27 $(6,158)$(1,446)$(19,242)
OCI before reclassifications3,450 (376)(807)(28)(136)(1)2,102 
Deferred income tax benefit (expense)(573)103 153 (52)— (364)
AOCI before reclassifications, net of income tax(11,629)(90)2,004 (6,346)(1,447)(17,504)
Amounts reclassified from AOCI514 (247)— — — 96 363 
Deferred income tax benefit (expense)(124)45 — — — (20)(99)
Amounts reclassified from AOCI, net of income tax390 (202)— — — 76 264 
Balance, end of period$(11,239)$(292)$2,004 $$(6,346)$(1,371)$(17,240)
__________________
(1)Primarily unrealized gains (losses) on fixed maturity securities.
Reclassification out of Accumulated Other Comprehensive Income (Loss)
Information regarding amounts reclassified out of each component of AOCI was as follows:
Three Months
Ended
September 30,
Nine Months
Ended
September 30,
2025202420252024
AOCI Components
Amounts Reclassified from AOCI
Consolidated Statements of
Operations and
Comprehensive Income (Loss)
Locations
(In millions)
Unrealized investment gains (losses):
Unrealized investment gains (losses)$(73)$(122)$(455)$(531)Net investment gains (losses)
Unrealized investment gains (losses)(1)— (9)— Net investment income
Unrealized investment gains (losses)12 61 17 Net derivative gains (losses)
Unrealized investment gains (losses), before income tax(62)(121)(403)(514)
Income tax (expense) benefit
12 33 87 124 
Unrealized investment gains (losses), net of income tax(50)(88)(316)(390)
Deferred gains (losses) on derivatives - cash flow hedges:
Interest rate derivatives
27 18 Net investment income
Interest rate derivatives
(27)(1)(18)(2)Net investment gains (losses)
Foreign currency exchange rate derivatives
Net investment income
Foreign currency exchange rate derivatives
(133)602 1,313 226 Net investment gains (losses)
Credit derivatives— Net investment gains (losses)
Gains (losses) on cash flow hedges, before income tax
(154)607 1,327 247 
Income tax (expense) benefit
34 (192)(271)(45)
Gains (losses) on cash flow hedges, net of income tax
(120)415 1,056 202 
Defined benefit plans adjustment: (1)
Amortization of net actuarial gains (losses)
(25)(35)(84)(104)
Amortization of prior service (costs) credit
Amortization of defined benefit plan items, before income tax
(22)(32)(75)(96)
Income tax (expense) benefit
17 20 
Amortization of defined benefit plan items, net of income tax
(18)(23)(58)(76)
Total reclassifications, net of income tax
$(188)$304 $682 $(264)
__________________
(1)These AOCI components are included in the computation of net periodic benefit costs. See Note 18.